entity

BBB_permeability

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about BBB_permeability: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

11Connections

2Hypotheses

6Analyses

0Outgoing

11Incoming

0Experiments

8Debates

No AI portrait yet

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (11)

Source	Relation	Type	Str
focused_ultrasound	activates	mechanism	0.90
ApoE4	activates	protein	0.80
circadian_regulation	modulates	pathway	0.80
Evans blue extravasation	biomarker_for	gene	0.70
Sodium fluorescein extravasation	biomarker_for	gene	0.70
circadian rhythm	associated_with	phenotype	0.70
IL1B	increases	gene	0.70
TNF	increases	gene	0.70
peripheral_infection	increases	process	0.70
TJP1	prevents	protein	0.70
C5AR1	increases	gene	0.50

Targeting Hypotheses (2)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Circulating Endothelial Microvesicles Expressing Degraded Cl	0.640	-	What blood-brain barrier permeability ch
IGFBPL1 Peptide Mimetics for Drug-Like BBB Permeability	0.397	drug-delivery	Can IGFBPL1 therapeutics effectively cro

Mentioning Analyses (6)

Scientific analyses that reference this entity

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

neurodegeneration | 2026-04-26 | 5 hypotheses Top: 0.712

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

neurodegeneration | 2026-04-16 | 14 hypotheses Top: 0.806

What is the optimal BBB opening duration and spatial precision to maximize thera

neuropharmacology | 2026-04-11 | 0 hypotheses

Extracellular vesicle biomarkers for early AD detection

neurodegeneration | 2026-04-02 | 0 hypotheses

Blood-brain barrier transport mechanisms for antibody therapeutics

neurodegeneration | 2026-04-01 | 14 hypotheses Top: 0.773

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (8)

Multi-agent debates referencing this entity

What is the evidence that blood-brain barrier (BBB) permeability changes serve a

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

Blood-brain barrier permeability changes as early biomarkers for neurodegenerati

closed · Rounds: 7 · Score: 0.50 · 2026-04-26

Should PEA-PPARA endocannabinoid signaling be prioritized as a therapeutic strat

closed · Rounds: 4 · Score: 0.76 · 2026-04-23

The debate highlighted focused ultrasound as most feasible but didn't resolve cr

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

closed · Rounds: 7 · Score: 0.87 · 2026-04-16

Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% brain penetrance. Engi

closed · Rounds: 4 · Score: 0.91 · 2026-04-06

Extracellular vesicle biomarkers for early AD detection

closed · Rounds: 4 · Score: 0.87 · 2026-04-02

What are the mechanisms underlying blood-brain barrier transport mechanisms for

closed · Rounds: 4 · Score: 0.94 · 2026-04-01

Related Research

Hypotheses and analyses mentioning BBB_permeability in their description or question text

No additional research found